Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

HKG/6896 stock hub

HKG/6896 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/6896is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.6B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/6896

In the news

Latest news · HKG/6896

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11.7P50 18.9P75 41.4

Trailing P/E9.5

P25 10.7P50 17.9P75 38.5

ROE17.7

P25 -14.7P50 2P75 9.4

ROIC24.1

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/6896 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

231

Groups with data

Currency

CNY

Showing 231 of 231 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Cayman Islands
Country code	HK
Employees	842
Employees Change	-32%
Employees Change Percent	-3.66
Enterprise value	HKD 2.2B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	KYG3961J1022
Last refreshed	2026-05-10
Market cap	HKD 2.6B
Price	HKD 3.58
Price currency	HKD
Rev Per Employee	1,249,603.77x
Sector	Healthcare
Sic	2834
Symbol	hkg/6896
Website	https://www.gxjsz.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	10.56%
EV Earnings	7.86x
EV/EBIT	6.44x
EV/EBITDA	5.8x
EV/FCF	25.32x
EV/Sales	2.09x
FCF yield	3.28%
P/B ratio	1.73x
P/E ratio	9.47x
P/S ratio	2.52x
PE Ratio10 Y	7.1x
PE Ratio3 Y	8.67x
PE Ratio5 Y	8.47x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	32.52%
EBITDA Margin	35.73%
FCF margin	8.27%
Gross margin	76.01%
Gross Profit	HKD 797.9M
Gross Profit Growth	-4.23%
Gross Profit Growth Q	-6.3%
Gross Profit Growth3 Y	-0.48%
Gross Profit Growth5 Y	-3.48%
Net Income	HKD 279.5M
Net Income Growth	-21.16%
Net Income Growth Q	-9.17%
Net Income Growth Years	0%
Net Income Growth3 Y	-1.42%
Net Income Growth5 Y	-6.24%
Pretax Margin	34.86%
Profit Margin	26.63%
Profit Per Employee	HKD 332,781
Profitable Years	13
ROA	8.44
Roa5y	9.43
ROCE	20.85
ROE	17.67
Roe5y	17.77
ROIC	24.09
Roic5y	29.22

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	1.63%
Cagr1y	-12.43%
Cagr3y	25.64%
Cagr5y	28.1%
Div CAGR3	11.57%
Div CAGR5	52.81%
EPS Growth	-21.16
EPS Growth Q	-9.17
EPS Growth Years	0
EPS Growth3 Y	-1.42
EPS Growth5 Y	-6.24
FCF Growth	-80.92%
FCF Growth Q	-59.78%
FCF Growth3 Y	-26.31%
FCF Growth5 Y	-27.48%
OCF Growth	-74.09%
OCF Growth Q	-60.14%
OCF Growth10 Y	-3.03%
OCF Growth3 Y	-17.47%
OCF Growth5 Y	-21.11%
Revenue Growth	-20.4x
Revenue Growth Q	-5.52x
Revenue Growth Years	0x
Revenue Growth3 Y	-2.13x
Revenue Growth5 Y	-4.04x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.42
Assets	HKD 2.5B
Cash	HKD 1.1B
Current Assets	HKD 2B
Current Liabilities	HKD 942.3M
Debt	HKD 650.2M
Debt EBITDA	HKD 1.72
Debt Equity	HKD 0.42
Debt FCF	HKD 7.49
Equity	HKD 1.5B
Interest Coverage	21.32
Liabilities	HKD 1B
Long Term Assets	HKD 502.5M
Long Term Liabilities	HKD 73M
Net Cash	HKD 449.6M
Net Cash By Market Cap	HKD 16.99
Net Cash Growth	-43.39%
Net Debt EBITDA	HKD -1.2
Net Debt Equity	HKD -0.29
Net Debt FCF	HKD -5.18
Tangible Book Value	HKD 1.5B
Tangible Book Value Per Share	HKD 2.07
WACC	3.11

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.17
Inventory Turnover	3.34
Net Working Capital	HKD 537.9M
Quick ratio	1.83
Working Capital	HKD 1.1B
Working Capital Turnover	HKD 1.04

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	-16.67%
Dividend Growth Years	0%
Dividend per share	HKD 0.34
Dividend Years	10
Dividend Yield	9.5%
Ex Div Date	2026-06-16
Last Dividend	HKD 0.5
Payout Frequency	Annual
Payout Ratio	134.82%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	17.53%
1Y total return	-12.42%
200-day SMA	3.53
3Y total return	98.36%
50-day SMA	3.48
50-day SMA vs 200-day SMA	50under200
5Y total return	244.9%
All Time High	8.47
All Time High Change	-57.73%
All Time High Date	2016-07-28
All Time Low	0.62
All Time Low Change	473.72%
All Time Low Date	2019-01-16
ATR	0.09
Beta	-0.15
Beta1y	-0.25
Beta2y	0.01
Ch YTD	17.38
High	3.62
High52	5.65
High52 Date	2025-05-29
High52ch	-36.64%
Low	3.57
Low52	3
Low52 Date	2026-03-09
Low52ch	19.33%
Ma50ch	2.81%
Price vs 200-day SMA	1.5%
RSI	50.59
RSI Monthly	51.98
RSI Weekly	54.82
Sharpe ratio	-0.11x
Sortino ratio	-0.01
Total Return	9.5%
Tr YTD	17.38
Tr1m	-2.72%
Tr1w	0.28%
Tr3m	11.88%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD 341.3M
Operating Income Growth	-9.54
Operating Income Growth Q	-12.65
Operating Income Growth3 Y	-4.15
Operating Income Growth5 Y	-7.22
Operating margin	32.52

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	223,288,300%
Net Borrowing	179,456,131.2
Shares Insiders	61.83%
Shares Institutions	0.48%
Shares Out	739,302,000
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD 86.8M
Average Volume	404,275x
Bv Per Share	2.07
CAPEX	HKD -50.4M
Ch10y	-48.86
Ch1m	-2.72
Ch1w	0.28
Ch1y	-20.97
Ch3m	11.88
Ch3y	32.1
Ch5y	100
Ch6m	3.77
Change	-1.1%
Change From Open	-0.83
Close	3.62
Days Gap	-0.28
Depreciation Amortization	34,941,877.7
Dollar Volume	819,820
Earnings Date	2026-03-27
EBIT	HKD 341.3M
EBITDA	HKD 375.1M
EPS	HKD 0.38
F Score	4
FCF	HKD 86.8M
FCF EV Yield	3.95x
FCF Per Share	HKD 0.12
Financing CF	-254,723,379
Fiscal Year End	December
Founded	1,956
Graham Number	4.19867
Graham Upside	17.28
Income Tax	HKD 86.4M
Investing CF	-61,227,933
Is Primary Listing	1
Last Earnings Date	2026-03-27
Last Report Date	2025-12-31
Lynch Fair Value	HKD 1.89
Lynch Upside	-47.19
Ma150	3.36
Ma150ch	6.42%
Ma20	3.61
Ma20ch	-0.83%
Net CF	-181,254,533
Open	3.61
P FCF Ratio	30.5
P OCF Ratio	19.29
Payment Date	2025-06-26
Position In Range	20
Ppne	546,334,906.9
Price Date	2026-05-08
Price EBITDA	HKD 7.06
Ptbv Ratio	1.73
Relative Volume	0.57x
Revenue	1,049,667,169x
Tax By Revenue	8.23x
Tax Rate	23.61%
Tr6m	3.77%
Volume	229,000
Z Score	3.47

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

HKG/6896 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+9.5%

$0.34 annual per share

Payout ratio

+134.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+52.8%

0 consecutive years of growth

Total shareholder yield

+9.5%

Next ex-dividend date: 2026-06-16

Performance

HKG/6896 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/6896?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.5%

Share of float held by funds and institutions

Insider ownership

+61.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

HKG/6896 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

50.6

Neutral momentum band

Price vs 200-day MA

+1.5%

50/200-day relationship not available

Beta (5Y)

-0.15

Less volatile than the market

Sharpe ratio

-0.11

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/6896

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/6896 stock rating?

hkg/6896 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/6896 analysis?

The full report lives at /stocks/hkg/6896/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/6896?

The latest report frames hkg/6896 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/6896 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.